Please enable JavaScript
Powered by Benchmark International Archives - Page 1683 of 1996 - Matribhumi Samachar English
Friday, April 24 2026 | 10:49:47 AM
Home / International (page 1683)

International

Ridgeline Minerals Announces Remaining 2024 Drill Results and Provides 2025 Budget Guidance for the Swift Project, Nevada

24.7 meters grading 0.5 g/t Au including 2.9 meters grading 1.9 g/t Au2025 Exploration Budget – US $5,000,000 Vancouver, British Columbia–(Newsfile Corp. – March 13, 2025) – Ridgeline Minerals Corp. (TSXV: RDG) (OTCQB: RDGMF) (FSE: 0GC0) (“Ridgeline” or the “Company”) is pleased to announce final assay results for core hole …

Read More »

Meridianbet (GMGI) Expands B2B Operations into Nigeria, Entering a Regulated $2 Billion Betting Market

Lagos, Valetta–(Newsfile Corp. – March 13, 2025) – Meridianbet, a subsidiary of Golden Matrix Group, Inc. (NASDAQ: GMGI), has officially launched its B2B operations in Nigeria, one of the largest and fastest-growing betting markets in Africa. The company’s entry into Nigeria further strengthens its 20-year presence in Africa, leveraging its …

Read More »

Velocity Acquires Copper-Gold Exploration Property in Northern Greece

Vancouver, British Columbia–(Newsfile Corp. – March 13, 2025) – Velocity Minerals Ltd. (TSXV: VLC) (OTCQB: VLCJF) (“Velocity” or the “Company”) provides an update on project generation work in northern Greece. The Company has been active in Greece for approximately 18 months, visiting historical mineral occurrences, completing geological mapping, rock sampling …

Read More »

Frontera Energy and CGX Energy Provide Update on Corentyne Block License

Toronto, Ontario–(Newsfile Corp. – March 13, 2025) – CGX Energy Inc. (TSXV: OYL) (“CGX”) and Frontera Energy Corporation (TSX: FEC) (“Frontera”) announced today that the joint venture (the “Joint Venture”), which was established through their respective subsidiaries in the Petroleum Agreement and the Petroleum Prospecting License for the Corentyne block …

Read More »

Neural Therapeutics Announces Closing of Financing, CSE Listing Approval, Completion of Previously Announced Transactions and Corporate Updates

Toronto, Ontario–(Newsfile Corp. – March 13, 2025) – Neural Therapeutics Inc. (“Neural” or the “Company”), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has completed the final tranche of its previously announced private placement …

Read More »